Radiation safe in lymph node-positive breast cancerRecurrence rates similar, swelling less common than with surgery Night shifts a breast cancer risk New cancer drugs release the brakes on the immune system Early trials of immunotherapy mark ‘new chapter’ in oncology Guidelines for prevention of acute antineoplastic-induced nausea and vomiting in children Pediatric Oncology Group of Ontario spearheads development of guidelines for the prevention of acute antineoplastic-induced nausea and vomiting in children. CUA: Testosterone level should guide androgen deprivation therapy Analysis shows importance of reaching low values CUA: Prostate inflammation cuts cancer risk Finding has implications for biopsy followup CUA: A new way to zap the prostate—MRI-guided laser ablation Outpatient procedure has low morbidity but high failure rate CUA: Survey reveals gaps in genitourinary cancer survivorship care Xtandi: new oral androgen receptor inhibitor for metastatic prostate cancer Drug is intended for patients who have undergone medical or surgical castration and who have received docetaxel therapy. Prostate cancer: More men can opt for active surveillance All conventional criteria need not be fulfilled, analysis shows First Previous 44 45 46 47 48 Next Last
